Enabling detection of HER2 and AR protein expression and localization in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)
Enabling detection of HER2 and AR protein expression and localization in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)